San Francisco, CA

INTERNATIONAL CYTOKINE AND INTERFERON SOCIETY INC

EIN 59-2471233

Health & Wellness Medical Research & Training

Mission

To promote original research in the fields of cytokines, interferons, chemokines, growth factors and their receptors; to facilitate multidisciplinary communication and integration of basic and clinical knowledge; to foster interactions between trainees and established researchers; and to support dissemination of biomedical knowledge through meetings, publications and educational activities.

IRS-recognized 501(c)(3) public charity Contributions are tax-deductible

Claim this page Visit cytokinesociety.org

About INTERNATIONAL CYTOKINE AND INTERFERON SOCIETY INC

The International Cytokine & Interferon Society (ICIS) is a member-driven 501(c)(3) scientific society focused on advancing research into cytokines, interferons, chemokines and related growth factors. The Society brings together academic, government and industry scientists and clinicians to accelerate basic, translational and clinical discoveries that impact cancer, autoimmunity, infectious disease and inflammation.

ICIS operates as a virtual office and delivers its mission through an active program of international annual meetings (the Cytokines series), member communications, awards and trainee support. The organization reports an active membership in the roughly one-thousand+ range and maintains an established program of travel awards, trainee prizes and recognition of scientific excellence to support career development in the field.

Notable achievements

Global annual meetings program

Sustained an international annual meeting series (Cytokines) that convenes researchers worldwide — recent meetings include Cytokines 2023 (Athens) and Cytokines 2024 (Seoul) — and routinely supports dozens to hundreds of trainee travel awardees and presenters.

Named trainee travel award (Joan Oefner)

Launched and endowed a named Student/Postdoc travel award in honor of long‑time Managing Director Joan Oefner (announced 2024/established for awards in 2024–2025), expanding support for early-career researchers to attend the Society’s annual meeting.

Membership and program growth

Expanded and sustained an international membership community of roughly one thousand+ scientists and physicians and broadened industry sponsorship and award endowments to increase trainee support and funded programming.

At a glance

Total assets: $751K
Annual revenue: $280K
Tax status: 501(c)(3)Public charity
EIN: 59-2471233
Location: San Francisco, CA
Website: cytokinesociety.org
On Mahalo since: April 2026

Financial figures from the IRS Business Master File, the IRS’s registry of tax-exempt organizations.

Recognition

Operates as a U.S. federal tax-exempt 501(c)(3) organization (federal tax ID: 59-2471233) and is incorporated as a learned scientific society.

Established awards and recognitions (including ICIS‑Pfizer trainee awards and multiple senior, mid‑career and young investigator prizes) that are well‑recognized within the cytokine/interferon research community.

Affiliations with reputable field journals and broad industry/academic sponsorship that support the Society’s meetings, travel awards and educational programs; also recognized as an approved learned society for certain tax relief purposes in international jurisdictions.

Is this your organization?

Claim this page to keep it current — add your logo, publish campaigns, and reach the donors and advisors discovering you on Mahalo.

Claim this page